World class operating partners with hundreds of years of collective experience scaling businesses across the healthcare, consumer and technology industries.
Former CEO of Liz Claiborne, Inc. and led the transformation to Kate Spade & Company in 2014; Former Company Group Chairman for DePuy Orthopedics within Johnson & Johnson; Former President of McNeil Consumer Healthcare
Mr. McComb has spent his career building and growing healthcare and consumer-driven companies and global brands, including PEPCID AC, TYLENOL, KATE SPADE and many others. Mr. McComb sits on the Board of Intrinsic’s marijuana breathalyzer portfolio company, Hound Labs, and provides strategic guidance and advice across Intrinsic’s portfolio companies and prospective investment opportunities.
Former CEO of Kraft Foods; Former Company Group Chairman for DePuy Orthopedics within Johnson & Johnson; Former President of McNeil Consumer Healthcare; Former President, Centocor Biologics
Mr. Vernon has spent his career building and growing healthcare and CPG companies and global brands, including PEPCID AC, TYLENOL, and KRAFT FOODS products. In addition, Mr. Vernon spent three years as Health Care Industry Partner at Ripplewood Holdings, LLC. Mr. Vernon provides strategic guidance and advice across Intrinsic’s portfolio companies and prospective investment opportunities.
Former Global Head of Supply Chain across multiple divisions within Johnson & Johnson, including Global Biologics and Jansen; Former WWVP of Quality at Warner Lambert (Pfizer)
Mr. Sheroff is a supply-chain expert who has run multi-billion dollar manufacturing operations. Mr. Sheroff sits on the Board of Intrinsic’s cannabis lab testing portfolio company, Act Labs, and provides strategic guidance across Intrinsic’s portfolio companies and operational diligence across prospective investment opportunities.
Former Commercial Executive within Johnson & Johnson; Former Global Head of One Touch Hospital Blood Glucose Monitoring Business; Former Head of TYLENOL Franchise at Johnson & Johnson
Mr. McDonagh has over 25 years of commercial healthcare leadership across consumer, medical device, and pharmaceutical business models. Mr. McDonagh was responsible for launching and growing key Johnson & Johnson brands such as TYLENOL, PEPCID AC and CONCERTA. Mr. McDonagh is leading Intrinsic’s Product Branding and Formulation Strategy across hemp-derived CBD medical and wellness products. Mr. McDonagh also consults on Act Labs commercial strategy.
Former Director, DDMAC of the FDA; Former Natl. Health Fraud Coord. of the FDA; Former WWVP of Reg. Affairs for Medical Devices & Diagnostics within Johnson & Johnson; Former VP of Medical & Reg. Affairs for McNeil Consumer Healthcare
Ms. Baylor-Henry has spent her career in medical regulatory affairs. Ms. Baylor-Henry provides extensive regulatory background and expertise across Intrinsic’s portfolio companies and prospective investment opportunities.
Former SVP Gilead Sciences Inc; Former Head of Quality across multiple divisions of Johnson & Johnson
Dr. Miller has a wealth of experience in the design and implementation of quality systems and guiding companies that are actively engaged in quality and compliance efforts in response to the FDA and other global regulatory agencies. Working with major global healthcare companies, Dr. Miller gained deep experience in diverse product portfolios, including solid and liquid dosage forms, API’s, Rx and over-the-counter products. Dr. Miller is the current Chief Operating Officer of Act Labs and serves as a Scientific Advisor to Intrinsic’s Product Branding and Formulation Strategy.
Executive Committee Member & Senior Managing Director of FS Investments; Former Corporate and Securities Council; Former State Legislator
Since 2012, Mr. Gerber has served as a top executive at FS Investments. As Executive Vice President of Administration, Communication and Public Affairs at FS Investments, Mr. Gerber manages firm administration, human resources, communications and the firm’s government affairs, regulatory and policy team and serves on the firm’s Executive Committee. Prior to joining FS Investments, Mr. Gerber practiced corporate and securities law at Drinker Biddle & Reath LLP. He previously served eight years in the Pennsylvania House of Representatives and six years as a trustee of Pennsylvania’s State Employees’ Retirement System, where he was a member of the Audit and Investment Committees.